Cargando…
Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents
Drug-induced lupus erythematosus (DILE) is a lupus-like syndrome temporally related to continuous drug exposure which resolves upon drug discontinuation. There are currently no standard diagnostic criteria for DILE. Findings include skin manifestations, arthritis, serositis, anti-nuclear and anti-hi...
Autores principales: | Dalle Vedove, Camilla, Simon, Jan C, Girolomoni, Giampiero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561694/ https://www.ncbi.nlm.nih.gov/pubmed/22937775 http://dx.doi.org/10.1111/j.1610-0387.2012.08000.x |
Ejemplares similares
-
Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
por: Gisondi, Paolo, et al.
Publicado: (2014) -
Anti-TNF-α Therapies in Systemic Lupus Erythematosus
por: Zhu, Lang-Jing, et al.
Publicado: (2010) -
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus
por: Bellinato, Francesco, et al.
Publicado: (2021) -
Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17
por: Richter, Patricia, et al.
Publicado: (2023) -
TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus
por: Idborg, Helena, et al.
Publicado: (2018)